You just read:

BioLineRx Presents Top-line Results from Phase 2a COMBAT/KEYNOTE-202 Study in Pancreatic Cancer at ESMO 2018 Congress

News provided by

BioLineRx Ltd.

Oct 19, 2018, 07:00 ET